<DOC>
	<DOCNO>NCT01711086</DOCNO>
	<brief_summary>Double-blind study , randomize , control , crossover . Study recruit 30 volunteer stable asthma age 8-18 year . Participants perform lung function part routine follow-up receive Foradil 12mcg either Aerolizer ( standard dry powder inhaler ) Inspiromatic ( active , breath synchronize innovative inhaler ) . 3-60 day later participant receive drug inhaler . Pre post treatment ( 15 min , 30 min , 60 min ) Lung function result , drug level blood , vital sign side effect record .</brief_summary>
	<brief_title>Safety Efficacy Inspiromatic Inhaler Comparison Aerolizer Inhaler When Delivering Formoterol</brief_title>
	<detailed_description />
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Children 818 year Asthma 50 &lt; FEV1 &lt; 80 Can perform Spirometry Poor cooperation Pregnancy Milk Allergy Other lung disease Prior familiarity Aerolizer</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>dry powder inhaler</keyword>
</DOC>